Literature DB >> 2162519

All subgenomic mRNAs of equine arteritis virus contain a common leader sequence.

A A de Vries1, E D Chirnside, P J Bredenbeek, L A Gravestein, M C Horzinek, W J Spaan.   

Abstract

During the replication of equine arteritis virus (EAV) six subgenomic mRNAs are synthesized. We present evidence that the viral mRNAs form a 3'-coterminal nested set and contain a common leader sequence of 208 nucleotides which is encoded by the 5'-end of the genome. The leader is joined to the bodies of mRNA 5 and 6 at positions defined by the sequence 5' UCAAC 3'. The part of the leader sequence flanking the UCAAC motif is very similar to the 5'-splice site of the Tetrahymena pre-rRNA. A possible internal guide sequence has been identified 43 nucleotides downstream of the leader sequence on the genome. Hybridization analysis shows that all EAV intracellular RNAs contain the leader sequence. These data imply that the viral subgenomic mRNAs are composed of leader and body sequences which are non-contiguous on the genome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162519      PMCID: PMC330929          DOI: 10.1093/nar/18.11.3241

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  The genome of equine arteritis virus.

Authors:  B A van der Zeijst; M C Horzinek
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized film.

Authors:  R A Laskey; A D Mills
Journal:  FEBS Lett       Date:  1977-10-15       Impact factor: 4.124

3.  Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping.

Authors:  L Jacobs; W J Spaan; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  Transformation of E. coli using homopolymer-linked plasmid chimeras.

Authors:  S L Peacock; C M McIver; J J Monahan
Journal:  Biochim Biophys Acta       Date:  1981-09-28

5.  Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.

Authors:  R A Lamb; C J Lai; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus.

Authors:  R A Lamb; C J Lai
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

7.  Togaviridae.

Authors:  J S Porterfield; J Casals; M P Chumakov; S Y Gaidamovich; C Hannoun; I H Holmes; M C Horzinek; M Mussgay; N Oker-Blom; P K Russell; D W Trent
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

8.  Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus.

Authors:  J T BRYANS; M E CROWE; E R DOLL; W H MCCOLLUM
Journal:  Cornell Vet       Date:  1957-01

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription.

Authors:  S J Plotch; M Bouloy; I Ulmanen; R M Krug
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

View more
  64 in total

1.  Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences.

Authors:  G van Marle; J C Dobbe; A P Gultyaev; W Luytjes; W J Spaan; E J Snijder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus.

Authors:  E Weiland; S Bolz; F Weiland; W Herbst; M J Raamsman; P J Rottier; A A De Vries
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Genetic manipulation of arterivirus alternative mRNA leader-body junction sites reveals tight regulation of structural protein expression.

Authors:  A O Pasternak; A P Gultyaev; W J Spaan; E J Snijder
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Regulation of relative abundance of arterivirus subgenomic mRNAs.

Authors:  Alexander O Pasternak; Willy J M Spaan; Eric J Snijder
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Secondary structure and function of the 5'-proximal region of the equine arteritis virus RNA genome.

Authors:  Erwin Van Den Born; Alexander P Gultyaev; Eric J Snijder
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

6.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs.

Authors:  R G van der Most; P J Bredenbeek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Isolation and characterization of an arterivirus defective interfering RNA genome.

Authors:  R Molenkamp; B C Rozier; S Greve; W J Spaan; E J Snijder
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Site-directed mutagenesis of the Nidovirus replicative endoribonuclease NendoU exerts pleiotropic effects on the arterivirus life cycle.

Authors:  Clara C Posthuma; Danny D Nedialkova; Jessika C Zevenhoven-Dobbe; Jeroen H Blokhuis; Alexander E Gorbalenya; Eric J Snijder
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  A complex zinc finger controls the enzymatic activities of nidovirus helicases.

Authors:  Anja Seybert; Clara C Posthuma; Leonie C van Dinten; Eric J Snijder; Alexander E Gorbalenya; John Ziebuhr
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

10.  Detection of equine arteritis virus following amplification of structural and nonstructural viral genes by reverse transcription-PCR.

Authors:  G St-Laurent; G Morin; D Archambault
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.